Jenburkt, second in India to launch Favipiravir (Favivent™) to fight COVID-19

Jenburkt, second in India to launch Favipiravir (Favivent™) to fight COVID-19

Mumbai, India; 24th July, 2020: ​India has recently crossed the 1.28 million* mark of COVID-19 cases and has turned into a global hotspot of coronavirus. In an important development for COVID-19 patients in India, ​Jenburkt Pharmaceuticals Ltd.​, a public…

Read more